Skip to main content
Premium Trial:

Request an Annual Quote

Metamark Genetics Buys HealthTronics' Anatomical Pathology Business

NEW YORK (GenomeWeb News) – Endo Health Solutions said late on Monday that its wholly owned subsidiary HealthTronics has sold its anatomical pathology business to Metamark Genetics for an undisclosed amount.

The business called HealthTronics Laboratory Solutions provides anatomical pathology services mainly to the urology community. Its labs are located in Georgia and Pennsylvania. It also manages pathology laboratories for physician practice groups, provides administrative services to in-office pathology labs for physical practice groups, and provides pathology services to physicians.

The sale of HealthTronics HLS comes as Endo Health pursues strategic alternatives for HealthTronics.

Metamark, based in Cambridge, Mass., develops prognostic and diagnostic tests for cancer using genomic and proteomic technologies. It plans to commercialize its ProMark prognostic prostate cancer test in 2013 through its CLIA laboratory.

In a statement Metamark President and CEO Shawn Marcell said "joining forces with HLS will be instrumental to our success" when it launches the ProMark test.

In November, Metamark raised $13 million in a Series B financing round as Mark Straley resigned as the company's president and CEO.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.